Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Clin Chem. 2011 Jun 23;57(8):1178–1187. doi: 10.1373/clinchem.2011.167544

Table 3.

Association of HDL Measures with Incident Hypertension

Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 LR
Chi2
P for
trend
HDL Cholesterol, mg/dL 15.9 – 42.4 42.5 – 49.7 49.9 – 56.9 57.0 – 66.5 66.6 –173.0
  Unadjusted 1 0.79 (0.72,0.88) 0.66 (0.59,0.73) 0.58 (0.52,0.64) 0.54 (0.49,0.60) 174.83 <0.001
  Model 1 1 0.94 (0.84,1.04) 0.85 (0.76,0.94) 0.78 (0.70,0.88) 0.79 (0.70,0.89) 25.25 <0.001
  Model 2 1 0.96 (0.86,1.06) 0.87 (0.78,0.97) 0.8 (0.72,0.9) 0.81 (0.71,0.91) 20.73 <0.001
Apolipoprotein A-I, mg/dL 49.8 –129 129.6 –143 143.4 –156 156.6 –172.9 173 – 249
  Unadjusted 1 0.88 (0.80,0.98) 0.84 (0.76,0.94) 0.88 (0.80,0.98) 0.85 (0.77,0.95) 12.70 0.008
  Model 1 1 0.96 (0.86,1.07) 0.98 (0.87,1.09) 1.07 (0.96,1.20) 1.03 (0.91,1.17) 4.63 0.23
  Model 2 1 0.97 (0.87,1.09) 0.99 (0.88,1.11) 1.07 (0.96,1.21) 1.01 (0.89,1.14) 3.46 0.41
NMR particle concentration, μmol/L
 Total HDL Particles 12.1 – 30.2 30.3 – 33.3 33.4 – 36.4 36.5 – 40.3 40.4 – 67.9
   Unadjusted 1 1.02 (0.92,1.14) 1.13 (1.01,1.26) 1.24 (1.12,1.38) 1.47 (1.32,1.63) 69.19 <0.001
   Model 1 1 1.02 (0.91,1.15) 1.12 (1.00,1.25) 1.23 (1.09,1.37) 1.48 (1.32,1.67) 54.81 <0.001
   Model 2 1 1.02 (0.91,1.15) 1.12 (1.00,1.25) 1.21 (1.08,1.36) 1.43 (1.26,1.61) 41.88 <0.001
 Large HDL Particles 0 – 4.7 4.8 – 6.9 7.0 – 8.9 9.0 –11.3 11.4 –25.3
   Unadjusted 1 0.74 (0.67,0.82) 0.62 (0.56,0.69) 0.51 (0.46,0.57) 0.56 (0.50,0.62) 200.89 <0.001
   Model 1 1 0.88 (0.79,0.98) 0.83 (0.75,0.93) 0.73 (0.65,0.82) 0.80 (0.71,0.9) 30.21 <0.001
   Model 2 1 0.90 (0.81,1.00) 0.86 (0.77,0.96) 0.76 (0.67,0.85) 0.81 (0.72,0.91) 24.29 <0.001
 Medium HDL Particles 0 – 0.5 0.6 – 1.8 1.9 – 3.8 3.9 – 7.0 7.1 – 30.4
   Unadjusted 1 1.12 (1.01,1.25) 1.15 (1.03,1.28) 1.27 (1.14,1.41) 1.43 (1.29,1.59) 52.12 <0.001
   Model 1 1 1.06 (0.95,1.18) 1.06 (0.95,1.18) 1.17 (1.05,1.30) 1.31 (1.17,1.46) 28.06 <0.001
   Model 2 1 1.05 (0.94,1.18) 1.04 (0.93,1.17) 1.14 (1.02,1.27) 1.26 (1.12,1.41) 18.878 <0.001
 Small HDL Particles 0 – 18.7 18.8 – 21.9 22.0 – 24.5 24.6 – 27.7 27.8 – 49.9
   Unadjusted 1 1.07 (0.96,1.19) 1.27 (1.14,1.42) 1.46 (1.31,1.63) 1.77 (1.59,1.97) 151.12 <0.001
   Model 1 1 0.98 (0.87,1.10) 1.11 (0.99,1.25) 1.17 (1.04,1.30) 1.36 (1.22,1.53) 45.35 <0.001
   Model 2 1 0.99 (0.88,1.11) 1.12 (1.00,1.25) 1.16 (1.04,1.30) 1.34 (1.20,1.50) 38.18 <0.001
Average NMR HDL Size, nm 8.0 – 8.6 8.7 – 8.9 9.0 – 9.2 9.3 – 9.5 9.6 – 10.8
  Unadjusted 1 0.73 (0.66,0.80) 0.57 (0.51,0.62) 0.49 (0.44,0.55) 0.40 (0.35,0.45) 338.06 <0.001
  Model 1 1 0.85 (0.77,0.94) 0.75 (0.68,0.84) 0.72 (0.64,0.80) 0.62 (0.55,0.7) 66.16 <0.001
  Model 2 1 0.86 (0.78,0.95) 0.77 (0.70,0.86) 0.74 (0.66,0.83) 0.65 (0.57,0.73) 52.73 <0.001

Ranges (minimum – maximum) and odds ratios with 95% confidence intervals are given for each quintile.

Model 1 includes age, smoking, fasting status, use of cholesterol lowering medication, trial treatment assignment, hormone use, menopausal status, race, exercise, alcohol use, body mass index, diabetes, education, vegetable, fruit, sodium, and total grain intake.

Model 2 adds C-reactive protein, homocysteine, fibrinogen, soluble inter-cellular adhesion molecule 1, and hemoglobin A1C to Model 1